Looking for a stock that might be in a good position to beat earnings at its next report? Consider Aegerion Pharmaceuticals, Inc. AEGR, a firm in the biopharmaceutical space, which could be a great candidate for another beat. …
Ocera Therapeutics Inc (OCRX): OCRX stock is up 20.67% today. Au Optronics Corp (AUO): AUO stock is up 15.18% today. Aegerion Pharmaceuticals (AEGR): AEGR stock is up 14.32% today. Heat Biologics Inc (HTBX): HTBX stock is …
but if investors have been misled and the number is actually 90% less, what will we value AEGR's stock price with a U.S. patient population of only 300? Here is a claim made in the third quarter conference call: "… I would emphasize that …
Aegerion /quotes/zigman/624094/delayed /quotes/nls/aegr AEGR shares climbed back up Monday by 16% to $81.65 after last week’s tumble, instantly putting the company’s stock back into the low-$80 range from the low-$70 level that it …
Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR) engages in the development and commercialization ... Aegerion closed Monday at $56.74. The stock is down more than 20% since the beginning of the year. Best Buy Co. Inc. (NYSE: BBY) …
Vbi Vaccines Inc (VBIV): VBIV stock is up 9.62% today. Impax Laboratories (IPXL): IPXL stock is up 9.39% today. Aegerion Pharmaceuticals (AEGR): AEGR stock is up 9.04% today. Tonix Pharm Hldg Cor (TNXP): TNXP stock is up …
One name in particular that got drilled viciously was Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR). The company posted a huge earnings miss and offered less than stellar guidance. To make things worse, the company’s stock was …
Aegerion Pharmaceuticals (AEGR) is a classic example of a much hyped biotech failing to deliver on its promise. In 2013, the company promised a great deal as its lead product candidate was approved by the FDA. That year saw the stock
Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR) should have a slogan that says “We love volatility.” The biotech stock now trades for just under $60 after its earnings report, but the 52-week trading range is $29.61 to $101.00. After a poor …
While difficult to predict, AEGR expects a new CEO hire could take 3-6 months." The analyst believes that the change in the top management could potentially restore investor confidence in the stock. Concerns regarding competition from the …